West Pharmaceutical Services (WST) Total Debt (2009 - 2026)

West Pharmaceutical Services has disclosed Total Debt across 18 years of filings, most recently posting $202.9 million for Q2 2026.

• In Q2 2026, Total Debt changed 0.15% year-over-year to $202.9 million; the TTM figure through Jun 2026 stood at $202.9 million (changed 0.15% YoY), while the FY2025 annual figure was $202.8 million, changed 0.1% from the prior year.
• Total Debt came in at $202.9 million for Q2 2026 at West Pharmaceutical Services, roughly flat from $202.8 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $340.8 million in Q4 2023 to a low of $202.6 million in Q3 2024.
• Average Total Debt over 5 years is $241.7 million, with a median of $211.4 million recorded in 2022.
• Year-over-year, Total Debt surged 61.44% in 2023 and tumbled 40.55% in 2024.
• Over 5 years, Total Debt stood at $211.1 million in 2022, then soared by 61.44% to $340.8 million in 2023, then plunged by 40.55% to $202.6 million in 2024, then gained by 0.1% to $202.8 million in 2025, then climbed by 0.05% to $202.9 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $202.9 million in Q2 2026, $202.8 million in Q1 2026, and $202.8 million in Q4 2025.